ArticleScientific reports2026
Integrative transcriptomic and machine learning approach reveals key DDR genes and predictors of ami risk in the Bangladeshi population.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Acute Myocardial Infarction (AMI) is a significant contributor to cardiovascular death, with rising prevalence in Bangladesh. Although DNA damage contributes to AMI pathogenesis, the role of DNA damage repair (DDR) genes remains poorly characterized. This study aims to identify key DDR genes associated with AMI, and develop a machine learning-based risk prediction model for the Bangladeshi population. Differentially expressed DDR genes in AMI were identified via bioinformatics analysis, with WGCNA revealing AMI-associated hub genes. These candidates were validated by qRT-PCR in Bangladeshi patients. A machine learning model using demographic and gene expression data was then trained using five classifiers. Differential expression and WGCNA identified Nibrin (NBN) and 8-Oxoguanine glycosylase (OGG1) as key dysregulated DDR genes. RT-qPCR confirmed a ~ 2.78-fold upregulation of OGG1 (p < 0.001) in AMI patients, while NBN expression was significantly higher in smokers (p < 0.05). Feature selection identified age, smoking, hypertension, diabetes, BMI, and OGG1 as critical AMI risk predictors. Logistic regression showed the best performance (accuracy 87.3%, AUC = 0.903). This study provides novel evidence linking DDR genes to AMI and presents a strong ML-based risk stratification model for the first time, integrating transcriptomic and clinical data from Bangladeshi patients to advance personalized AMI management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.